Yantai Dongcheng Pharmaceutical Group Co.,Ltd.
Shenzhen Stock ExchangeTotal Valuation
Yantai Dongcheng Pharmaceutical Group Co.,Ltd. carries a market capitalization of 10.51B, placing it among publicly traded companies globally. Its enterprise value stands at 12.72B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 10.51B |
| Enterprise Value | 12.72B |
Share Statistics
Yantai Dongcheng Pharmaceutical Group Co.,Ltd. currently has 824.60M shares outstanding.
| Shares Outstanding | 824.60M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
Yantai Dongcheng Pharmaceutical Group Co.,Ltd. trades at a trailing price-to-earnings ratio of 73.83. The price-to-sales ratio is 4.19, and the price-to-book ratio stands at 5.27.
| PE Ratio | 73.83 |
| PS Ratio | 4.19 |
| PB Ratio | 5.27 |
| P/TBV Ratio | 4.92 |
| P/FCF Ratio | 32.10 |
| P/OCF Ratio | N/A |
Enterprise Valuation
On an enterprise value basis, Yantai Dongcheng Pharmaceutical Group Co.,Ltd. trades at an EV/EBITDA multiple of 31.55 and an EV/FCF ratio of 30.62. The EV/Sales ratio of 4.49 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 31.55 provides insight into valuation relative to core operating earnings.
| EV / Sales | 4.49 |
| EV / EBITDA | 31.55 |
| EV / EBIT | 31.55 |
| EV / FCF | 30.62 |
Financial Position
Yantai Dongcheng Pharmaceutical Group Co.,Ltd. maintains a current ratio of 1.65, meaning it holds 1.6x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 15.29, indicating elevated leverage, while an interest coverage ratio of 4.63 demonstrates adequate ability to service its debt obligations.
| Current Ratio | 1.65 |
| Quick Ratio | 0.59 |
| Debt / Equity | 15.29 |
| Debt / EBITDA | 2.07 |
| Interest Coverage | 4.63 |
Financial Efficiency
Yantai Dongcheng Pharmaceutical Group Co.,Ltd. posts a return on equity of 7.23 and a return on invested capital of 3.35.
| Return on Equity (ROE) | 7.23 |
| Return on Assets (ROA) | 1.82 |
| Return on Invested Capital (ROIC) | 3.35 |
| Return on Capital Employed (ROCE) | 6.79 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 2.16 |
Taxes
Over the trailing twelve months, Yantai Dongcheng Pharmaceutical Group Co.,Ltd. has paid 82.23M in income taxes, reflecting an effective tax rate of 47.32.
| Income Tax | 82.23M |
| Effective Tax Rate | 47.32 |
Stock Price Statistics
Yantai Dongcheng Pharmaceutical Group Co.,Ltd.'s stock has declined approximately -11.64241% over the past 52 weeks. The 50-day moving average sits at 12.75, while the 200-day moving average is 13.82.
| Beta (5Y) | N/A |
| 52-Week Price Change | -11.64241% |
| 50-Day Moving Average | 12.75 |
| 200-Day Moving Average | 13.82 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Yantai Dongcheng Pharmaceutical Group Co.,Ltd. generated 2.83B in revenue and converted that into 160.69M in net income, yielding earnings per share of 0.11. EBITDA reached 403.15M, while operating income came in at 403.15M.
| Revenue | 2.83B |
| Gross Profit | 1.36B |
| Operating Income | 403.15M |
| Pretax Income | 173.76M |
| Net Income | 160.69M |
| EBITDA | 403.15M |
| EBIT | 403.15M |
| Earnings Per Share (EPS) | 0.11 |
Balance Sheet
Yantai Dongcheng Pharmaceutical Group Co.,Ltd. holds 943.41M in cash and equivalents against 833.93M in total debt, resulting in a net debt position of -110.13M. Total book value stands at 2.25B, with working capital of 1.04B providing operational flexibility.
| Cash & Cash Equivalents | 943.41M |
| Total Debt | 833.93M |
| Net Debt | -110.13M |
| Equity (Book Value) | 2.25B |
| Book Value Per Share | 2.73 |
| Working Capital | 1.04B |
Cash Flow
After subtracting -369.61M in capital expenditures, free cash flow totaled -369.61M - equivalent to -0.45 per share.
| Operating Cash Flow | N/A |
| Capital Expenditures | -369.61M |
| Free Cash Flow | -369.61M |
| FCF Per Share | -0.45 |
Margins
Yantai Dongcheng Pharmaceutical Group Co.,Ltd. operates with a gross margin of 48.11, reflecting its pricing power and cost economics. The operating margin of 14.24 and net profit margin of 5.67 provide insight into operational efficiency.
| Gross Margin | 48.11 |
| Operating Margin | 14.24 |
| Pretax Margin | 6.14 |
| Profit Margin | 5.67 |
| EBITDA Margin | 14.24 |
Dividends & Yields
The company's payout ratio of 694.12 indicates the proportion of earnings distributed to shareholders.
| Dividend Per Share | 0.19 |
| Dividend Yield | N/A |
| Payout Ratio | 694.12 |
| Shareholder Yield | 1.56 |
| FCF Yield | 3.12 |
Stock Splits
Yantai Dongcheng Pharmaceutical Group Co.,Ltd.'s most recent stock split took place on August 30, 2016 with a 1:3 split ratio.
| Last Split Date | 8/30/2016 |
| Split Ratio | 1:3 |
Scores
Yantai Dongcheng Pharmaceutical Group Co.,Ltd. posts an Altman Z-Score of 3.29, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 3.29 |